Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
BACKGROUND
An elevated serum remnant lipoprotein cholesterol (RLP-C)/triglyceride (TG) ratio has not been evaluated as an index of familial type III hyperlipidaemia defined by the presence of beta-VLDL and apolipoprotein (Apo) E2/2 phenotype in the Japanese hyperlipidaemic population.


METHODS
Serum lipids and lipoproteins from 514 individuals (200 men and 314 women, mean age 58 years) with total cholesterol >6.22 mmol/L and TG between 2.26 mmol/L and 9.04 mmol/L, selected from 25,080 subjects visiting the clinics for health checkup were analysed for a possible relationship with familial type III hyperlipoproteinaemia.


RESULTS
Median RLP-C concentration and RLP-C/TG ratio were 0.30 and 0.11 mmol/L, respectively. When compared between subjects with (31 cases) and without (483 cases) a broad-beta band on electrophoresis, the RLP-C concentrations and RLP-C/TG ratio were 0.77 +/- 0.43 mmol/L versus 0.34 +/- 0.16 mmol/L (P<0.0001) and 0.15 +/- 0.023 versus 0.11 +/- 0.027 (P<0.0001), respectively. Three cases with broad-beta band positive (the presence of beta-VLDL) showed RLP-C/TG ratio greater than 0.23 and RLP-C greater than 0.78 mmol/L, suggestive of type III hyperlipoproteinaemia, despite a lack of characteristic Apo E2/2 homozygosity. Cases with Apo E/Apo CIII ratio greater than 1.0 were not detected in this study group.


CONCLUSIONS
Serum RLP-C concentration and RLP-C/TG ratio, together with Apo E/Apo CIII ratio appear to be useful for screening familial type III hyperlipidaemia in the Japanese hyperlipidaemic population.
Japan Immunoresearch Laboratories, Takasaki, Japan. nakajimak05@ybb.ne.jp
Katsuyuki
K
Nakajima
Masahiro
M
Daimon
Kiyoshi
K
Kamiyama
Kunihiko
K
Takanashi
Yukiko
Y
Suzuki
Masakazu
M
Watanabe
Katsuo
K
Kubono
Abby R
AR
Saniabadi
Sei-ichi
S
Takashima
Ikunosuke
I
Sakurabayashi
D000293:Adolescent; D000328:Adult; D000368:Aged; D053305:Apolipoprotein C-III / Q000097:blood; D053329:Apolipoprotein E2 / Q000097:blood; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis; D006952:Hyperlipoproteinemia Type III / Q000097:blood / Q000175:diagnosis*; D008074:Lipoproteins / Q000097:blood*; D053419:Lipoproteins, IDL / Q000097:blood; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*
D053305:Apolipoprotein C-III; D053329:Apolipoprotein E2; D001053:Apolipoproteins; D008074:Lipoproteins; D053419:Lipoproteins, IDL; D014280:Triglycerides; C030104:lipoprotein cholesterol; C112017:remnant-like particle cholesterol; D002784:Cholesterol